Illumina 測序組合試劑盒DX-102-1003

Illumina公司，致力于新一代測序和芯片技術(shù)的生產(chǎn)與開發(fā)，提供產(chǎn)品與應(yīng)用資訊

Illumina/MiSeqDx Cystic Fibrosis 139-Variant Assay (20 runs, 960 samples)/DX-102-1003/1 Ea
產(chǎn)品編號(hào)： DX-102-1003
美  元  價(jià)： $0.00
會(huì)  員  價(jià)： 待定
品       牌： Illumina
產(chǎn)       地： 美國
公       司： Illumina, Inc.
產(chǎn)品分類： 其它>其它試劑>臨床研究
公司分類： In Vitro Diagnostic (IVD) Products

Illumina公司創(chuàng)立于1998年4月，是遺傳變異和生物學(xué)功能分析領(lǐng)域的優(yōu)秀的產(chǎn)品、技術(shù)和服務(wù)供應(yīng)商。通過幫助客戶加快實(shí)現(xiàn)生物信息的采集、分析和應(yīng)用，來改善人類健康。

Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products

上海易匯生物科技有限公司于17年正式銷售Illumina公司基因芯片、二代測序NGS測序儀及相關(guān)測序試劑盒等產(chǎn)品

咨詢illumina MiSeq測序試劑盒等產(chǎn)品歡迎您致電 上海易匯生物科技有限公司：1850 1609 238張經(jīng)理

Product Highlights:

Compared to the current ACMG recommended cystic fibrosis variant panel, the MiSeqDx Cystic Fibrosis 139-Variant Assay offers:

• Improved Detection Rates of Cystic Fibrosis-Causing Variants
  Detection of couples at risk increased from 72% to ~91%1
• Reduced Additional Testing
  Highly accurate and reproducIBLe sequencing technology delivers dependable results

The MiSeqDx Cystic Fibrosis 139-Variant Assay is an FDA-cleared in vitro diagnostic (IVD) next-generation sequencing test designed to detect 139 CFTR variants as defined in the CFTR2 database. Other methods test only for those variants most commonly found in Caucasians, potentially missing CF-causing variants across broader ethnic groups. The MiSeqDx Cystic Fibrosis 139-Variant Assay offers the largest CF variant panel to overcome this bias and provide comprehensive detection across diverse demographics.2

Widely adopted next-generation sequencing

The MiSeqDx Cystic Fibrosis 139-Variant Assay provides a fully integrated molecular CF testing solution on the MiSeqDx instrument. Simply prepare libraries from 250 ng gDNA, load on to the MiSeqDx for sequencing using Illumina sequencing by synthesis (SBS) chemistry, and analyze with the user-friendly software. The automated workflow is quick and easy to perform, potentially minimizing human error.

A complete kit for library preparation and sequencing

The MiSeqDx Cystic Fibrosis 139-Variant Assay includes all index primers and reagents needed for library preparation, sample multiplexing, and sequencing in a single kit. MiSeqDx sequencing reagents are packaged in a convenient ready-to-use format, minimizing hands-on time and increasing uniformity in all tests. To accommodate a broad spectrum of testing needs, from small to large volumes, the assay is available in two kit configurations (2 or 20 runs).

Specifications:

Illumina 測序組合試劑盒DX-102-1003